Morrissey Michael M.'s Insider Trades & SAST Disclosures
Morrissey Michael M.'s most recent trade in Exelixis Inc was a trade of 184,909 Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Morrissey Michael M..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 184,909 | 1,033,290 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 177,985 | 848,381 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 177,985 | 1,764,985 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.00 per share. | 15 Feb 2025 | 63,570 | 1,026,366 (0%) | 0% | 35 | 2,224,950 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,552 | 81,515 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.47 per share. | 21 Jan 2025 | 429 | 70,963 (0%) | 0% | 73.5 | 31,519 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 473,226 | 1,210,180 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.27 per share. | 16 Jan 2025 | 120,244 | 1,089,936 (0%) | 0% | 37.3 | 4,481,494 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 908 | 71,392 (0%) | 0% | 72.5 | 65,794 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2024 | 179,788 | 736,954 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | M. Michael Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Dec 2024 | 179,788 | 1,587,000 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.05 per share. | 15 Nov 2024 | 47,642 | 916,742 (0%) | 0% | 35.0 | 1,669,852 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2024 | 46,000 | 1,407,212 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.41 per share. | 01 Oct 2024 | 480,000 | 1,444,384 (0%) | 0% | 24.4 | 11,716,800 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 480,000 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.30 per share. | 01 Oct 2024 | 463,702 | 980,682 (0%) | 0% | 26.3 | 12,195,363 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Oct 2024 | 16,298 | 1,453,212 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Oct 2024 | 16,298 | 964,384 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 15 May 2024 | 39,681 | 964,384 (0%) | 0% | 21.0 | 832,904 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.99 per share. | 15 May 2024 | 34,262 | 1,004,065 (0%) | 0% | 21.0 | 719,159 | Common Stock |
| Vera Therapeutics Inc - Or... | Michael M. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 14,000 | 14,000 | - | - | Stock Option (right to buy) | |
| Exelixis Inc | Morrissey Michael M. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 241,670 | 1,038,327 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Morrissey Michael James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.50 per share. | 22 Jan 2024 | 108 | 72,300 (0%) | 0% | 61.5 | 6,642 | Common Stock |
| Incyte Corp. | James Morrissey Michael | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 61.18 per share. | 18 Jan 2024 | 11,359 | 72,530 (0%) | 0% | 61.2 | 694,944 | Common Stock |
| Incyte Corp. | Michael Morrissey James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.49 per share. | 18 Jan 2024 | 122 | 72,408 (0%) | 0% | 61.5 | 7,502 | Common Stock |
| Incyte Corp. | Morrissey Michael James | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.48 per share. | 16 Jan 2024 | 101 | 61,171 (0%) | 0% | 61.5 | 6,209 | Common Stock |
| Incyte Corp. | Morrissey James Michael | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.34 per share. | 16 Jan 2024 | 101 | 61,272 (0%) | 0% | 61.3 | 6,195 | Common Stock |
| Exelixis Inc | M. Morrissey Michael | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 250,374 | 860,374 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.86 per share. | 11 Jan 2024 | 63,717 | 796,657 (0%) | 0% | 22.9 | 1,456,571 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.31 per share. | 28 Aug 2023 | 360,000 | 945,496 (0%) | 0% | 15.3 | 5,511,600 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 360,000 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.18 per share. | 28 Aug 2023 | 303,779 | 641,717 (0%) | 0% | 22.2 | 6,737,818 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.51 per share. | 15 Aug 2023 | 23,304 | 585,496 (0%) | 0% | 21.5 | 501,269 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.18 per share. | 15 May 2023 | 33,518 | 608,800 (0%) | 0% | 19.2 | 642,875 | Common Stock |
| Vera Therapeutics Inc - Or... | Michael M. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 313,185 | 642,318 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.08 per share. | 15 Feb 2023 | 11,522 | 329,133 (0%) | 0% | 18.1 | 208,318 | Common Stock |
| Selective Insurance Group ... | Michael J. Morrissey | Director | Sale of securities on an exchange or to another person at price $ 101.21 per share. | 06 Feb 2023 | 4,000 | 12,578 (0%) | 0% | 101.2 | 404,836 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 37,994 | 1,340,320 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 37,994 | 340,655 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jan 2023 | 106,010 | 1,302,326 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jan 2023 | 106,010 | 340,655 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2023 | 100,000 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 24 Jan 2023 | 100,000 | 440,655 (0%) | 0% | 4.2 | 420,000 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.36 per share. | 24 Jan 2023 | 62,006 | 378,649 (0%) | 0% | 17.4 | 1,076,424 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 6,159 | 61,373 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.88 per share. | 19 Jan 2023 | 105 | 55,214 (0%) | 0% | 83.9 | 8,807 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.26 per share. | 15 Jan 2023 | 87 | 55,319 (0%) | 0% | 81.3 | 7,070 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.26 per share. | 15 Jan 2023 | 87 | 55,406 (0%) | 0% | 81.3 | 7,070 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.08 per share. | 04 Jan 2023 | 117 | 55,493 (0%) | 0% | 79.1 | 9,252 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.71 per share. | 15 Nov 2022 | 23,304 | 446,665 (0%) | 0% | 16.7 | 389,410 | Common Stock |
| Vera Therapeutics Inc - Or... | Michael M. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Selective Insurance Group ... | Michael J. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 1,727 | 16,566 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 270,415 | 399,271 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2022 | 50,000 | 1,196,316 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.59 per share. | 15 Feb 2022 | 59,044 | 128,856 (0%) | 0% | 18.6 | 1,097,628 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.59 per share. | 15 Feb 2022 | 6,103 | 187,900 (0%) | 0% | 18.6 | 113,455 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.35 per share. | 24 Jan 2022 | 78 | 55,610 (0%) | 0% | 75.3 | 5,877 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 6,959 | 55,688 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.01 per share. | 18 Jan 2022 | 101 | 48,830 (0%) | 0% | 75.0 | 7,576 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.01 per share. | 18 Jan 2022 | 101 | 48,729 (0%) | 0% | 75.0 | 7,576 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.81 per share. | 04 Jan 2022 | 136 | 48,931 (0%) | 0% | 71.8 | 9,766 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 3,615 | 49,067 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 11,003 | 194,003 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 11,003 | 1,246,316 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.10 per share. | 15 Nov 2021 | 177,132 | 367,288 (0%) | 0% | 18.1 | 3,206,089 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.10 per share. | 15 Nov 2021 | 10,530 | 550,538 (0%) | 0% | 18.1 | 190,593 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.10 per share. | 15 Nov 2021 | 6,118 | 544,420 (0%) | 0% | 18.1 | 110,736 | Common Stock |
| Selective Insurance Group ... | Michael J. Morrissey | Director | Sale of securities on an exchange or to another person at price $ 74.99 per share. | 09 Jun 2021 | 3,000 | 20,829 (0%) | 0% | 75.0 | 224,970 | Common Stock |
| Selective Insurance Group ... | Michael J. Morrissey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 1,610 | 23,825 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Sale of securities on an exchange or to another person at price $ 81.08 per share. | 29 Mar 2021 | 20,000 | 45,452 (0%) | 0% | 81.1 | 1,621,600 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 494,700 | 494,700 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2021 | 67,374 | 491,813 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2021 | 67,374 | 1,059,683 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.91 per share. | 15 Feb 2021 | 9,789 | 559,187 (0%) | 0% | 21.9 | 214,477 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 224,287 | 634,166 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2021 | 187,239 | 1,118,874 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2021 | 187,239 | 386,641 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Feb 2021 | 126,565 | 992,309 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.56 per share. | 03 Feb 2021 | 65,190 | 568,976 (0%) | 0% | 22.6 | 1,470,686 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 23,238 | 409,879 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.50 per share. | 25 Jan 2021 | 78 | 65,452 (0%) | 0% | 100.5 | 7,839 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 11,522 | 59,943 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 5,761 | 65,704 (0%) | 0% | 0 | Common Stock | |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.96 per share. | 15 Jan 2021 | 174 | 65,530 (0%) | 0% | 94.0 | 16,349 | Common Stock |
| Incyte Corp. | Michael James Morrissey | EVP, Head of Tech. Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.45 per share. | 04 Jan 2021 | 136 | 48,421 (0%) | 0% | 86.4 | 11,757 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.16 per share. | 15 Nov 2020 | 10,530 | 581,778 (0%) | 0% | 20.2 | 212,285 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.16 per share. | 15 Nov 2020 | 7,898 | 573,880 (0%) | 0% | 20.2 | 159,224 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.16 per share. | 15 Nov 2020 | 6,526 | 592,308 (0%) | 0% | 20.2 | 131,564 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2020 | 672,861 | 775,966 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.79 per share. | 22 Oct 2020 | 177,132 | 598,834 (0%) | 0% | 21.8 | 3,859,706 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Oct 2020 | 42,500 | 989,135 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Oct 2020 | 32,500 | 931,635 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Oct 2020 | 25,000 | 964,135 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2020 | 23,238 | 109,223 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.58 per share. | 02 Sep 2020 | 6,118 | 103,105 (0%) | 0% | 21.6 | 132,026 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 100,000 | 0 | - | - | Option (right to buy) | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.21 per share. | 20 Jul 2020 | 100,000 | 185,985 (0%) | 0% | 6.2 | 621,000 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.60 per share. | 20 Jul 2020 | 64,137 | 121,848 (0%) | 0% | 25.6 | 1,641,907 | Common Stock |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jul 2020 | 35,863 | 1,031,635 (0%) | 0% | 0 | Common Stock | |
| Exelixis Inc | Michael M. Morrissey | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jul 2020 | 35,863 | 85,985 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges